Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
Authors
Podcasts
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
Authors
Podcasts
About
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
More
You are here
Home
lupus erythematosus, systemic
Email alerts
lupus erythematosus, systemic
Hydroxychloroquine shortages during the COVID-19 pandemic
Arielle
Mendel
,
Sasha
Bernatsky
,
J Carter
Thorne
,
Diane
Lacaille
,
Sindhu R
Johnson
,
Évelyne
Vinet
Annals of the Rheumatic Diseases
Mar 2021,
80
(3)
e31;
DOI:
10.1136/annrheumdis-2020-217835
Correspondence on ‘Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus under long-term treatment with hydroxychloroquine’
Mandana
Nikpour
,
Benjamin
Teh
,
Ian P
Wicks
,
Marc
Pellegrini
Annals of the Rheumatic Diseases
Mar 2021,
80
(3)
e33;
DOI:
10.1136/annrheumdis-2020-217827
Response to: ‘Correspondence on ‘Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus under long-term treatment with hydroxychloroquine’’ by Nikpour
et al
Alexis
Mathian
,
Zahir
Amoura
Annals of the Rheumatic Diseases
Mar 2021,
80
(3)
e34;
DOI:
10.1136/annrheumdis-2020-217875
Patients with lupus with COVID-19: University of Michigan experience
Beth
Wallace
,
Laraine
Washer
,
Wendy
Marder
,
J Michelle
Kahlenberg
Annals of the Rheumatic Diseases
Mar 2021,
80
(3)
e35;
DOI:
10.1136/annrheumdis-2020-217794
Response to: ‘Patients with lupus with COVID-19: University of Michigan experience’ by Wallace
et al
Alexis
Mathian
,
Zahir
Amoura
Annals of the Rheumatic Diseases
Mar 2021,
80
(3)
e36;
DOI:
10.1136/annrheumdis-2020-217910
Rheumatic disease and COVID-19
Jean W
Liew
,
Elizabeth R
Graef
Annals of the Rheumatic Diseases
Mar 2021,
80
(3)
e43;
DOI:
10.1136/annrheumdis-2020-217674
Is there a future for hydroxychloroquine/chloroquine in prevention of SARS-CoV-2 infection (COVID-19)?
Sergey
Moiseev
,
Sergey
Avdeev
,
Michail
Brovko
,
Pavel
Novikov
,
Victor
Fomin
Annals of the Rheumatic Diseases
Feb 2021,
80
(2)
e19;
DOI:
10.1136/annrheumdis-2020-217570
Response to ‘Is there a future for hydroxychloroquine/chloroquine in prevention of SARS-CoV-2 infection (COVID-19)?’ by Moiseev
et al
Francesca Romana
Spinelli
,
Fulvia
Ceccarelli
,
Manuela
Di Franco
,
Fabrizio
Conti
Annals of the Rheumatic Diseases
Feb 2021,
80
(2)
e20;
DOI:
10.1136/annrheumdis-2020-217636
Patients with lupus are not protected from COVID-19
Amr H
Sawalha
Annals of the Rheumatic Diseases
Feb 2021,
80
(2)
e21;
DOI:
10.1136/annrheumdis-2020-217656
No evidence so far on the protective effect of hydroxychloroquine to prevent COVID-19: comment by Joob and Wiwanitkit
Vasco C.
Romão
,
Ana Rita
Cruz-Machado
,
João Eurico
Fonseca
Annals of the Rheumatic Diseases
Feb 2021,
80
(2)
e22;
DOI:
10.1136/annrheumdis-2020-217665
Pages
1
2
3
4
5
6
next ›
last »
CLINICAL
Diagnostics
Clinical diagnostic tests
(1563)
Radiology (diagnostics)
(921)
Surgical diagnostic tests
(505)
Drugs and medicines
Endocrinology
Calcium and bone
(938)
Evidence based practice
Guidelines
(35)
Gastroenterology
Inflammatory bowel disease
(98)
Genetics
(1272)
Immunology (including allergy)
(6648)
Infectious diseases
Bone and joint infections
(93)
Travel medicine
(42)
Neurology
Muscle disease
(198)
Pain (neurology)
(1113)
Nutrition and metabolism
Obesity (nutrition)
(142)
Obstetrics and gynaecology
Menopause (including HRT)
(60)
Ophthalmology
(155)
Orthopaedics
Pathology
Inflammation
(1572)
Pathology
(531)
Pharmacology and therapeutics
Unwanted effects / adverse reactions
(15)
Pharmacology and therapeutics
Radiology
(1357)
Rehabilitation medicine
Disability
(32)
Other rehabilitative therapies
(18)
Physiotherapy
(52)
Renal medicine
(247)
Respiratory medicine
Interstitial lung disease
(181)
Pulmonary hypertension
(39)
Rheumatology
Ankylosing spondylitis
(567)
Biological agents
(731)
Connective tissue disease
(5506)
Degenerative joint disease
(6038)
Drugs: musculoskeletal and joint diseases
(916)
Fibromyalgia
(51)
Musculoskeletal syndromes
(6412)
Osteoarthritis
(1189)
Osteoporosis
(160)
Rheumatoid arthritis
(4213)
Sjogren's syndrome
(6)
Systemic lupus erythematosus
(724)
Vascularitis
(367)
Sports and exercise medicine
Physiotherapy
(33)
NON-CLINICAL
Epidemiology
(1862)
Health economics
(51)
Medical education
Postgraduate
(5)
Occupational and environmental medicine
(32)
Statistics and research methods
Special collections
ARD Lay summaries
(83)
Editor's choice
(161)
Guidelines, Recommendations and Consensus Statements
Open access
(1199)
Press releases
(50)
